CDH11 and breast carcinoma: MDA-MB-231 CDH11-expressing breast cancer cells were inoculated into nude mice and treated MatrigelTM with a function-blocking monoclonal CDH11-specific antibody that does not exhibit significant side-effects in inflammatory RA, or control IgG [6].